These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3928148)

  • 1. Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning system.
    Von Hoff DD; Forseth B; Warfel LE
    Cancer Res; 1985 Sep; 45(9):4032-8. PubMed ID: 3928148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of chemotherapy for patient treatment utilizing a radiometric versus a cloning system.
    Von Hoff DD; Forseth BJ; Turner JN; Clark GM; Warfel LE
    Int J Cell Cloning; 1986 Jan; 4(1):16-26. PubMed ID: 3950456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiometric method for evaluation of chemotherapy sensitivity: results of screening a panel of human breast cancer cell lines.
    Arteaga CL; Forseth BJ; Clark GM; Von Hoff DD
    Cancer Res; 1987 Dec; 47(23):6248-53. PubMed ID: 3119196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a human tumor colony-forming assay to new drug screening.
    Shoemaker RH; Wolpert-DeFilippes MK; Kern DH; Lieber MM; Makuch RW; Melnick NR; Miller WT; Salmon SE; Simon RM; Venditti JM
    Cancer Res; 1985 May; 45(5):2145-53. PubMed ID: 3986767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New screening system for selection of anticancer drugs for treatment of human colorectal cancer.
    Scheithauer W; Clark GM; Moyer MP; Von Hoff DD
    Cancer Res; 1986 Jun; 46(6):2703-8. PubMed ID: 3698003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in experimental chemotherapy of colorectal cancer].
    Scheithauer W
    Acta Med Austriaca; 1987; 14(5):118-24. PubMed ID: 3439421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone.
    Lathan B; Von Hoff DD; Elslager E
    Cancer Treat Rep; 1984 May; 68(5):733-8. PubMed ID: 6233003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of the anticancer drug modulatory effect of hyaluronidase in human gastrointestinal cell lines.
    Scheithauer W; Temsch EM; Stefenelli T; Lathan B
    Anticancer Res; 1988; 8(3):391-5. PubMed ID: 3389743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.
    Marshall MV; Marshall MH; Degen DR; Roodman GD; Kuhn JG; Ross ME; Von Hoff DD
    Stem Cells; 1993 Jan; 11(1):62-9. PubMed ID: 8457783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for in vitro chemosensitivity assay: inhibition of metabolic CO2 production.
    Kurnick NB; Coats HA; de Jesus I
    Biomed Pharmacother; 1983; 37(7):351-3. PubMed ID: 6421339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer drugs: effect on the cloning of Raji lymphoma cells in soft agar.
    Wu PC; Ozols RF; Hatanaka M; Boone CW
    J Natl Cancer Inst; 1982 Jan; 68(1):115-21. PubMed ID: 6948121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of in vitro assays for the cytotoxic effect of anticancer drugs].
    Li XT; Lin C; Li PY
    Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):184-6. PubMed ID: 3743346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R; Koessler AK; Howel SB
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro methods for assessing cytotoxic activity against two pancreatic adenocarcinoma cell lines.
    Chang BK
    Cancer Res; 1983 Jul; 43(7):3147-9. PubMed ID: 6850624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects.
    Garewal HS; Ahmann FR; Schifman RB; Celniker A
    J Natl Cancer Inst; 1986 Nov; 77(5):1039-45. PubMed ID: 3464795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of oxaliplatin against human tumor colony-forming units.
    Raymond E; Lawrence R; Izbicka E; Faivre S; Von Hoff DD
    Clin Cancer Res; 1998 Apr; 4(4):1021-9. PubMed ID: 9563898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assays for new drug screening: comparison of a thymidine incorporation assay with the human tumor colony-forming assay.
    Hildebrand-Zanki SU; Kern DH
    Int J Cell Cloning; 1987 Sep; 5(5):421-31. PubMed ID: 3624922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified screening system to select new cytostatic drugs.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical antitumor activity of the oral platinum analog satraplatin.
    Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences in troxacitabine pharmacokinetics and pharmacodynamics: implications for clinical development.
    Gourdeau H; Leblond L; Hamelin B; Dong K; Ouellet F; Boudreau C; Custeau D; Richard A; Gilbert MJ; Jolivet J
    Clin Cancer Res; 2004 Nov; 10(22):7692-702. PubMed ID: 15570003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.